Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 7 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.
Dear all,
Please see below the updated links for external funding:
External funding opportunities: http://www.uib.no/en/med/112772/external-funding-opportunities
Funding opportunities for education: http://www.uib.no/med/113987/funding-opportunities-education
The webpages are updated every second week. New calls are marked as NEW.
Kind regards,
Amra, Ramune and Kaia
Benedicte Sjo Tiselvoll is a PhD fellow at K2. She started in the fall of 2018 and was before this a research line student and completed her medical studies in the spring of 2018. She works at Bjørn Tore Gjertsen’s research group (Ths signaling-targeted therapy group), focusing on early treatment response in acute myelogenous leukemia (AML) using mass cytometry (CyTOF) ). If you want to say hello, she can be contacted by email: benedicte.tislevoll@uib.no
Hi, my name is Zaidon Salim. I started working as a researcher in the Diabetes stem cell group at the Department of Clinical Science (K2) in February 2019. I work mainly on developing MODY-3 stem cells derived pancreatic cells transplantation in a living host. Email: zaidon.salim@uib.no
Ingvild Vistad
Ingvild Vistad has been employed as part-time professor since March 2019. Her main workplace is Sørlandet Hospital Kristiansand. She is a specialist in gynecology and obstetrics, and her research fields are primarily quality of life and follow-up after gynecological cancer. Her e-mail address is: ingvild.vistad@uib.no
In 2013, a new organizational structure was introduced at K2. The most important elements are that
The purpose of the research groups is to conduct research according to the regulations, ethical guidelines, and the Environment, Health, and Security (EHS) requirements that apply at UiB.
The tasks are among others to
It is now six years since this structure was introduced. After site visits during spring 2018, it became clear that adjustments are necessary due to natural retirement and changes in activity for some of the groups. We have therefore initiated a process to chane the composition of some of the research groups. Permanent scientific staff for relevant groups will be called. Key questions for discussions will be
After a discussion with the relevant groups, some new groups will be formed and leaders appointed. Feel free to contact me by mail regarding input in this process.
Happy Hilydays!
På oppdrag fra Helse- og omsorgsdepartementet utarbeider de regionale helseforetakene årlig rapport for Forskning og innovasjon til pasientens beste.
I årets nasjonale rapport er EILO/ILO-gruppens forskning omtalt i tillegg til å pryde forsiden.
Se hele rapporten her.
Resultatene finner du her.
If you are interested in Translational Medicine and would like to hear about the job profiles of scientists in industry, you should consider joining the TMex course which will take place 11-15 November 2019 in Barcelona. You can get more info and register on this page, and here is the programme as it stands now:
Agnethe Lund will defend his PhD thesis on Thursday 13th June 2019
Trial lecture: Thursday 13th June 2019 at 10.15.
Topic: “Intrauterine fetal death in pregestational diabetes mellitus – incidence and etiology?”
Place: Auditorium, KK, Jonas Lies vei 92
Public defense: Thursday 13th June at 12.15
Title of dissertation: “Maternal diabetes mellitus and fetal venous liver flow —a longitudinal study”
Place: Auditorium, KK, Jonas Lies vei 92
1st opponent: Professor Emeritus Gerard Visser, University Medical Center, Utrecht, The Netherlands
2nd opponent: Ph.d. Ane Moe Holme, Oslo University Hospital, Oslo
3rd member of the comittee: Associate Professor Eirik Søfteland, Universitetet i Bergen
The defense will be led by Professor Nils-Halvdan Morken
Audun Osland Vik-Mo will defend her PhD thesis on Friday 14th June 2019
Trial lecture: Friday 14th June 2019 at 09.15.
Topic: “Etiological and neuropathological basis/causes of NPS in Alzheimer’s disease and Dementia with Lewy bodies”
Place: Aulaen psyk. helsevern, Stavanger Universitetssykehus,Gerd-Ragna Bloch Thorsens gate 8
Public defense: Friday 14th June 2019 at 11.00.
Title of dissertation: “Neuropsychiatric symptoms in dementia: long-term course and neuropathology”
Place:Aulaen psyk. helsevern, Stavanger Universitetssykehus,Gerd-Ragna Bloch Thorsens gate 8
1st opponent: Professor Gill Livingston, University College London
2nd opponent: Ph.d. Karin Persson, Norwegian National Advisory Unit for Ageing and Health, Oslo
3rd medlem av komiteen: Førsteamanuensis Bjarte Stubhaug, Universitetet i Bergen
The defense will be led by Dennis Nilsen.
Brita Skodvin will defend her PhD thesis on Friday 14th June 2019
Trial lecture: Friday 14th June 2019 at 09.15.
Topic: “Antimicrobial stewardship – rationale, current challenges and prospects for the future”.
Place: Auditorium, AHH, Haukelandsveien 28
Public defense: Friday 14th June 2019 at 11.15.
Title of dissertation: “Addressing the threat of AMR in Norway: optimizing antibiotic prescribing and microbiology testing in hospitals”
Place: Auditorium, AHH, Haukelandsveien 28
1st opponent: Ph.d. Jeroen Schouten, Radboud University Medical Center, The Netherlands
2nd opponent: Professor Jan Frich, Universitetet i Oslo
3rd member of the comittee: Forsker Marianne Øksnes, Universitetet i Bergen
The defense will be led by Professor Elling Ulvestad.